Results 281 to 290 of about 5,007,317 (352)

Overall and disease-free survival in patients with HPV-positive and HPV-negative oropharyngeal cancer. [PDF]

Einstein (Sao Paulo)
Abreu M, Oliveira DMA, Bastos Neto BC, Germano JN, Kowalski LP, Curado MP.   +5 more
europepmc   +1 more source

Nominal plan robustness may predict plan degradation in proton therapy for oropharyngeal head‐and‐neck cancer

Journal of Applied Clinical Medical Physics, Volume 27, Issue 5, May 2026.
Abstract Background Proton therapy for head‐and‐neck (HN) cancer offers superior organ‐at‐risk sparing compared to photon therapy, but is challenged by frequent anatomical changes during treatment. These changes need to be monitored with routine verification CTs (vCTs), which are used to trigger adaptive replans when deemed necessary by the clinical ...
Mark J. Zakhary, Daniel Redell, David Alicia, Jenna Jatczak, Nrusingh C. Biswal, Sina Mossahebi, Kai Sun, Reid Bark, Jason K. Molitoris, Byongyong Yi   +9 more
wiley   +1 more source

Lymphatic mapping Of Oropharyngeal Cancer (LOOC): protocol for a phase II surgical imaging trial to evaluate contralateral drainage and occult metastasis in oropharyngeal cancer. [PDF]

BMJ Open
Schilling C, Payne K, Wan S, Brew-Graves C, Ofo E, Ambler G, Weller A, Gnanasegaran G, Paleri V, Shaw R, Fleming J, Walker D, Bajwa M, McGurk M.   +13 more
europepmc   +1 more source

Immune Checkpoint Inhibitors and Immunomodulators for Cancer Immunotherapy: Insights Into Resistance and Therapeutic Strategies

Advanced Science, Volume 13, Issue 25, 4 May 2026.
The schematic diagram illustrates the roles of novel immune checkpoints, immunomodulatory factors, cell death and multimodal technologies in cancer immunotherapy. Abstract Cancer immunotherapy has redefined cancer treatment. However, the molecular and cellular basis of immune evasion and therapeutic resistance remains incompletely understood.
Fangquan Chen, Yang Yu, Xiutao Cai, Junhao Lin, Ruirui Liang, Rui Kang, Daolin Tang, Jiao Liu   +7 more
wiley   +1 more source

Comparison of surgical and non surgical treatment strategies for non metastatic oropharyngeal cancer using inverse probability weighting. [PDF]

Discov Oncol
Dubray-Vautrin A, Choussy O, Bozec L, Le Tourneau C, Calugaru V, Graff P, Taouachi R, Lesnik M, Badois N, Mullaert J.   +9 more
europepmc   +1 more source

The Role of Neopterin and Interleukin-6 Detection in Saliva and Plasma in Oral and Oropharyngeal Cancer Patients: A Prospective Study. [PDF]

Clin Exp Dent Res
Šašková L, Tvrdý P, Melichar B, Tomandl J, Zapletalová J, Mozol'a M, Michl P, Král D, Pink R.   +8 more
europepmc   +1 more source

Evaluation of an HPV16-L1 antibody rapid test for oropharyngeal cancer diagnosis: diagnostic accuracy and challenges in real-world settings. [PDF]

EBioMedicine
Kusters JMA, Brenner N, Bogaards JA, Silling S, El-Zein M, Gray P, Kann H, Franco EL, Lehtinen M, Dietz A, Laban S, Klussmann JP, Wieland U, Waterboer T.   +13 more
europepmc   +1 more source

Salivary and Serum Liquid Biopsy Biomarkers for HPV-Associated Oral and Oropharyngeal Cancer: A Narrative Review. [PDF]

J Clin Med
Warnakulasuriya S, Patil S.
europepmc   +1 more source

Epidemiological Trends in the Characterization of Human Papillomavirus Virus-Related Oropharyngeal Cancer: A Global Perspective. [PDF]

Curr Oncol Rep
Chen AM.
europepmc   +1 more source